Olink Holding AB (publ) (OLK)

NASDAQ: OLK · IEX Real-Time Price · USD
22.29
-0.38 (-1.65%)
Apr 17, 2024, 2:03 PM EDT - Market open
-1.65%
Market Cap 2.77B
Revenue (ttm) 169.60M
Net Income (ttm) -31.60M
Shares Out 124.34M
EPS (ttm) -0.25
PE Ratio n/a
Forward PE 185.19
Dividend n/a
Ex-Dividend Date n/a
Volume 288,277
Open 22.59
Previous Close 22.66
Day's Range 22.25 - 22.97
52-Week Range 14.10 - 26.01
Beta 0.50
Analysts Hold
Price Target 26.00 (+16.67%)
Earnings Date May 9, 2024

About OLK

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom de... [Read more]

Sector Healthcare
IPO Date Mar 25, 2021
Employees 707
Stock Exchange NASDAQ
Ticker Symbol OLK
Full Company Profile

Financial Performance

In 2023, OLK's revenue was $169.60 million, an increase of 21.27% compared to the previous year's $139.85 million. Losses were -$31.60 million, 145.9% more than in 2022.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for OLK stock is "Hold." The 12-month stock price forecast is $26.0, which is an increase of 16.67% from the latest price.

Price Target
$26.0
(16.67% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Olink reports fourth quarter and full year 2023 financial results

UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the fourth quarter ended December 31, 2023.

23 days ago - GlobeNewsWire

Notice to attend the Annual General Meeting of Olink Holding AB (publ)

UPPSALA, Sweden, March 15, 2024 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the “Company” or “Olink”), reg. no. 559189-7755, are hereby given notice to attend the Annual General M...

4 weeks ago - GlobeNewsWire

Olink announces change of date for Annual General Meeting

UPPSALA, Sweden, March 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Olink's 2024 Annual General Meeting (“AGM”) will be held in Uppsala, Sweden on...

5 weeks ago - GlobeNewsWire

Olink reports third quarter 2023 financial results

UPPSALA, Sweden, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the third quarter ended September 30, 2023.

5 months ago - GlobeNewsWire

Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics

Novogene AMEA to begin offering Olink Explore HT high-throughput proteomics services to unravel the connections between genes, proteins, and diseases.

5 months ago - GlobeNewsWire

OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Olink Holding AB...

Other symbols: TMO
5 months ago - Business Wire

Thermo Fisher Scientific Commences Tender Offer for All Outstanding Common Shares and ADSs of Olink

WALTHAM, Mass. & UPPSALA, Sweden--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK)...

Other symbols: TMO
6 months ago - Business Wire

OLK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Olink Holding AB (publ) Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Olink Holding AB (publ) (NASDAQ: OLK) to Thermo Fisher Scientific Inc. for $26.00 per com...

6 months ago - Business Wire

Thermo Fisher to Buy Sweden's Olink for $3.1 Billion

Thermo Fisher will acquire proteomics company Olink for $26 per American depositary share in cash.

Other symbols: TMO
6 months ago - Barrons

Thermo Fisher's stock slips after deal to buy Sweden's Olink for a 74% premium

Thermo Fisher Scientific Inc. TMO, +1.18% announced Tuesday an agreement to buy Sweden-based proteomics company Olink Holding AB OLK, +0.47% in a deal that values Olink at about $3.1 billion, includin...

Other symbols: TMO
6 months ago - Market Watch

Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics

WALTHAM, Mass. & UPPSALA, Sweden--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK)...

Other symbols: TMO
6 months ago - Business Wire

Landmark studies utilizing Olink® Explore technology signal a new era for population-scale proteogenomics

UPPSALA, Sweden, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today reported the publication of three articles in the prestigious scientific journal, Nature, that demonstrat...

6 months ago - GlobeNewsWire

Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.

Discover more with less. Unmatched specificity and sensitivity deliver translational insights from 1µl of sample. Discover more with less. Unmatched specificity and sensitivity deliver translational i...

7 months ago - GlobeNewsWire

Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs

Uppsala, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Eurofins Genomics a dopts Olink ® technology to advance proteomics research and accelerate precision medicine programs

7 months ago - GlobeNewsWire

Olink to participate in September investor events

UPPSALA, Sweden, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events:

8 months ago - GlobeNewsWire

Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform

UPPSALA, Sweden, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC) has sel...

9 months ago - GlobeNewsWire

Olink to report second quarter 2023 financial results on August 9, 2023, and to participate in the Canaccord Genuity 43rd Annual Growth Conference

UPPSALA, Sweden, July 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the second quarter of 2023 before the market op...

9 months ago - GlobeNewsWire

Announcing Olink® Explore HT – A New Era in Proteomics

A High-throughput Protein Biomarker Discovery Platform with Proven Specificity at Any Scale A High-throughput Protein Biomarker Discovery Platform with Proven Specificity at Any Scale

10 months ago - GlobeNewsWire

Revealing the secrets of the human proteome with Olink® Insight: Exploring findings from one of the world's largest health studies

UPPSALA, Sweden, June 28, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the availability of new findings into the variability of the human proteome, based on measureme...

10 months ago - GlobeNewsWire

Olink to participate in June investor events

UPPSALA, Sweden, May 25, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Company management will participate in the following investor events:

11 months ago - GlobeNewsWire

Olink reports first quarter 2023 financial results

UPPSALA, Sweden, May 11, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial results for the first quarter ended March 31, 2023.

1 year ago - GlobeNewsWire

Report from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023

UPPSALA, Sweden, April 17, 2023 (GLOBE NEWSWIRE) -- At the A nnual G eneral M eeting (the “AGM”) of Olink Holding AB (publ), reg. no 55 9189 - 7755 , (the “Company”), on 1 7 April 202 3 the AGM adopte...

1 year ago - GlobeNewsWire

Olink to report first quarter 2023 financial results on May 11, 2023

UPPSALA, Sweden, April 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the first quarter of 2023 before the market op...

1 year ago - GlobeNewsWire

Swedish Olink technology enables further development of South African research and innovation

UPPSALA, Sweden, March 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink tec...

1 year ago - GlobeNewsWire

Olink publishes 2022 annual report

UPPSALA, Sweden, March 27, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual Report for 2022 is now available on the Company's website at https:/...

1 year ago - GlobeNewsWire